Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.

Kalinowska-Łyszczarz A, Pawlak MA, Michalak S, Paprzycki W, Losy J.

J Neuroimmunol. 2011 Dec 15;240-241:109-13. doi: 10.1016/j.jneuroim.2011.10.002. Epub 2011 Oct 29.

PMID:
22036954
2.

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.

Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F.

Scand J Immunol. 2003 May;57(5):493-7.

3.

PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy.

De Masi R, Vergara D, Pasca S, Acierno R, Greco M, Spagnolo L, Blasi E, Sanapo F, Trianni G, Maffia M.

J Neuroimmunol. 2009 May 29;210(1-2):80-6. doi: 10.1016/j.jneuroim.2009.03.002. Epub 2009 Mar 29.

PMID:
19329191
4.

Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.

Kalinowska-Łyszczarz A, Pawlak MA, Michalak S, Losy J.

J Neurol Sci. 2012 Oct 15;321(1-2):43-8. doi: 10.1016/j.jns.2012.07.044. Epub 2012 Aug 9.

PMID:
22877509
5.

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.

Caggiula M, Batocchi AP, Frisullo G, Angelucci F, Patanella AK, Sancricca C, Nociti V, Tonali PA, Mirabella M.

Clin Immunol. 2006 Jan;118(1):77-82. Epub 2005 Nov 7.

PMID:
16275091
6.

Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Farhum F, Karni A.

J Neurol Sci. 2010 Aug 15;295(1-2):31-7. doi: 10.1016/j.jns.2010.05.019. Epub 2010 Jun 11.

PMID:
20541775
7.

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.

Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK, Sancricca C, Mirabella M, Tonali PA, Batocchi AP.

J Neurosci Res. 2006 Oct;84(5):1027-36.

PMID:
16865709
8.

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A.

J Neuroimmunol. 2011 Mar;232(1-2):171-8. doi: 10.1016/j.jneuroim.2010.10.007. Epub 2010 Nov 26.

PMID:
21111488
9.

Corpus callosum index and long-term disability in multiple sclerosis patients.

Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N.

J Neurol. 2010 Aug;257(8):1256-64. doi: 10.1007/s00415-010-5503-x. Epub 2010 Mar 3.

PMID:
20198382
10.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
11.

Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.

Caggiula M, Batocchi AP, Frisullo G, Angelucci F, Patanella AK, Sancricca C, Nociti V, Tonali PA, Mirabella M.

Scand J Immunol. 2005 Aug;62(2):176-82.

12.

Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.

Vaneckova M, Kalincik T, Krasensky J, Horakova D, Havrdova E, Hrebikova T, Seidl Z.

Eur Neurol. 2012;68(1):23-7. doi: 10.1159/000337683. Epub 2012 Jun 6.

PMID:
22677920
13.

Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients.

Patanella AK, Zinno M, Quaranta D, Nociti V, Frisullo G, Gainotti G, Tonali PA, Batocchi AP, Marra C.

J Neurosci Res. 2010 Apr;88(5):1106-12. doi: 10.1002/jnr.22276.

PMID:
19885866
14.

The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.

Lindquist S, Hassinger S, Lindquist JA, Sailer M.

Mult Scler. 2011 Jul;17(7):851-66. doi: 10.1177/1352458511399797. Epub 2011 May 11.

PMID:
21561957
15.

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2011 Jun;235(1-2):91-7. doi: 10.1016/j.jneuroim.2011.03.012. Epub 2011 Apr 20.

PMID:
21507492
16.

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

Paolillo A, Pozzilli C, Gasperini C, Giugni E, Mainero C, Giuliani S, Tomassini V, Millefiorini E, Bastianello S.

J Neurol Sci. 2000 Mar 15;174(2):85-91.

PMID:
10727693
17.

Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks.

Blanco-Jerez C, Plaza JF, Masjuan J, Orensanz LM, Alvarez-Cermeño JC.

J Neuroimmunol. 2002 Jul;128(1-2):90-4.

PMID:
12098515
18.

Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.

Liguori M, Fera F, Gioia MC, Valentino P, Manna I, Condino F, Cerasa A, La Russa A, Clodomiro A, Paolillo A, Nisticò R, Vercillo L, Cittadella R, Quattrone A.

Genes Brain Behav. 2007 Mar;6(2):177-83.

19.

Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.

Sarchielli P, Zaffaroni M, Floridi A, Greco L, Candeliere A, Mattioni A, Tenaglia S, Di Filippo M, Calabresi P.

Mult Scler. 2007 Apr;13(3):313-31. Epub 2007 Jan 29.

PMID:
17439900
20.

Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Karni A.

J Neuroimmunol. 2011 Sep 15;238(1-2):96-103. doi: 10.1016/j.jneuroim.2011.08.003. Epub 2011 Aug 31.

PMID:
21880375
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk